Roy Y Kim

Senior Scientist @ Montara Therapeutics, Inc.

About

Highly motivated scientist with 15 years of experience in conducting in vivo pharmacological and translational studies.

Country

United States

City

San Francisco

Industry

Biotechnology

Skill

Chemical Hazards, Scientific Research, Research Skills, Pharmacokinetics, qRT-PCR, PK, Biomarkers, Mammalian Cell Culture, Autoimmunity, Autoimmune Diseases, Pharmacodynamics, Non-clinical, Neurodegenerative Disease, In Vivo, Drug Development, Animal Handling, Pharmacology, Toxicology, Good Laboratory Practice (GLP), Biotechnology Industry

Experience

Senior Scientist

Montara Therapeutics, Inc.

2024-1 - Present · 2 yrs 9 mos

San Francisco Bay Area

Pharmacology

Scientist

Mitokinin Inc

2018-8 - 2022-12 · 4 yrs 5 mos

San Francisco Bay Area

Performed in vivo and in vitro pharmacological and translational studies to test Mitokinin’s small molecule PINK1 activators in Parkinson’s Disease models. Conducted all pre-clinical stage experiments of Mitokinin’s lead drugs, contributing to GLP and IND enabling studies.

Graduate Student Researcher

UCLA

2012-9 - 2018-7 · 5 yrs 11 mos

Characterized neuroprotective mechanisms of estrogen receptor beta (ERβ) ligands in mouse models of Multiple Sclerosis (MS). Validated therapeutic effects of ERβ-ligand pro-drugs in mouse models of MS and established strong relationship with collaborator Michael Jung, Ph.D. at UCLA.

Research Assistant

NCIRE - The Veterans Health Research Institute at UCSF

2009-7 - 2012-7 · 3 yrs 1 mo

Conducted in vivo studies in models of hyperlipidemia and hypercholesterolemia, to characterize the effects of ApoE4 isoform versus ApoE3 in atherosclerosis progression and regression. Investigated therapeutic effects of FTY720 (fingolimod) on mouse models of occlusive coronary atherosclerosis/heart failure in collaboration with Joel Karliner MD at UCSF.